AKC - Overview: Adenylate Kinase Enzyme Activity, Blood
Assessment of adenylate kinase activity as part of the evaluation of chronic nonspherocytic hemolytic anemia
ALFP - Overview: Alpha-Fetoprotein (AFP) Immunostain, Technical Component Only
Aiding in the identification of yolk sac tumors and hepatocellular carcinoma
HQ - Overview: HemoQuant, Feces
Detection of blood in feces Evaluation of iron deficiency Detection of bleeding as a complication of anticoagulant therapy and other medication regimens This test is not specific for bowel cancer.
FENTS - Overview: Fentanyl, Serum
Monitoring fentanyl therapy
FLUOX - Overview: Fluoxetine, Serum
Monitoring serum concentration of fluoxetine during therapy Evaluating potential toxicity Evaluating patient compliance
OXCO1 - Overview: Oxalate, Random, Urine
Monitoring therapy for kidney stones Identifying increased urinary oxalate as a risk factor for stone formation Diagnosis of primary or secondary hyperoxaluria
PCPMC - Overview: Phencyclidine (PCP) Confirmation, Meconium
Detection of in utero to phencyclidine (PCP) exposure up to 5 months before birth
MDSDF - Overview: Myelodysplastic Syndrome (MDS), Diagnostic FISH, Varies
Detecting a neoplastic clone associated with the common chromosome abnormalities seen in patients with myelodysplastic syndromes or other myeloid malignancies using a laboratory-designated probe set algorithm Evaluating specimens in which...
FHV8P - Overview: Herpesvirus 8 (HHV-8) DNA, Quantitative Real-Time PCR
Herpesvirus 8 (HHV-8) DNA, Quantitative Real-Time PCR
Identification of individuals who may be at risk for aminoglycoside-induced hearing loss (AIHL) Establishing a diagnosis of late-onset sensorineural hearing loss associated with aminoglycoside exposure Identifying mitochondrial variants...
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....